Plain-English translation of NCT05642858 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether receiving educational text messages can help people living with HIV lower their risk of heart disease. Researchers will send participants 3–5 text messages per week for up to 6 months with information about HIV, heart disease risk, and ways to protect heart health. The study wants to see if this simple, accessible approach helps prevent serious heart problems.
People living with HIV face a higher risk of heart disease and related conditions, even with modern HIV treatment. This study explores whether regular, practical education delivered through text messages—a tool most people use every day—can help reduce that risk and improve overall heart health.
You likely qualify if…
You likely don't qualify if…
If you are selected for this study, you will be placed into one of two groups. One group will receive 3–5 educational text messages per week for up to 6 months about HIV and heart disease prevention; the other group will not receive these messages. Both groups will complete brief surveys once a month through a digital platform. The study lasts about 6 months, and your main commitment is reading and engaging with the messages and completing the monthly check-ins.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
United States
Sponsor
University of California, San Francisco
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Enrollment target
~260 participants
Started
March 2023
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
40 Years and older
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Megan McLaughlin, MD, MPH
University of California, San Francisco
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.